Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f360 (Published 28 January 2013)
Cite this as: BMJ 2013;346:f360

Related articles

Research: The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis

Research Methods & Reporting: Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

Research Methods & Reporting: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Education and debate: Interaction revisited: the difference between two estimates

Paper: Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

Paper: Bias in meta-analysis detected by a simple, graphical test

See more

Research: Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis

Editorial: Chronic hypertension during pregnancy

News: In brief

Editorial: Does US health reform reduce hospital readmission rates?

Feature: Diabetes Team of the Year: adaptable and supportive

This article has been cited by other articles: